Alpha 2.0
Login Register
» Articles » PMID: 32389846

Ascertainment Rate of Novel Coronavirus Disease (COVID-19) in Japan

Overview
Journal Int J Infect Dis
Publisher Elsevier
Specialty Infectious Diseases
Date 2020 May 12
PMID 32389846
Citations 49
Authors
Ryosuke Omori
Kenji Mizumoto
Hiroshi Nishiura
Affiliations
Soon will be listed here.
Abstract

Objective: To estimate the ascertainment rate of novel coronavirus disease (COVID-19).

Methods: The epidemiological dataset of confirmed cases with COVID-19 in Japan as of February 28, 2020 was analyzed. A statistical model was constructed to describe the heterogeneity of the reporting rate by age and severity. We estimated the number of severe and non-severe cases, accounting for under-ascertainment.

Results: The ascertainment rate of non-severe cases was estimated at 0.44 (95% confidence interval 0.37-0.50), indicating that the unbiased number of non-severe cases would be more than twice the reported count.

Conclusions: Severe cases are twice as likely to be diagnosed and reported when compared to other cases. Considering that reported cases are usually dominated by non-severe cases, the adjusted total number of cases is also approximately double the observed count. This finding is critical in interpreting the reported data, and it is advised that the mild case data for COVID-19 should always be interpreted as under-ascertained [Au?1].

Citing Articles

Underreporting of Cases in the COVID-19 Outbreak of Borriana (Spain) during Mass Gathering Events in March 2020: A Cross-Sectional Study.

Domenech-Montoliu S, Pac-Sa M, Sala-Trull D, Del Rio-Gonzalez A, Sanchez-Urbano M, Satorres-Martinez P Epidemiologia (Basel). 2024; 5(3):499-510.

PMID: 39189253 PMC: 11348374. DOI: 10.3390/epidemiologia5030034.

Modeling the heterogeneity in COVID-19's reproductive number and its impact on predictive scenarios.

Donnat C, Holmes S J Appl Stat. 2023; 50(11-12):2518-2546.

PMID: 37554662 PMC: 10405777. DOI: 10.1080/02664763.2021.1941806.

Using real-time ascertainment rate estimate from infection and hospitalization dataset for modeling the spread of infectious disease: COVID-19 case study in the Czech Republic.

Pribylova L, Eclerova V, Majek O, Jarkovsky J, Pavlik T, Dusek L PLoS One. 2023; 18(7):e0287959.

PMID: 37440522 PMC: 10343065. DOI: 10.1371/journal.pone.0287959.

Design of effective outpatient sentinel surveillance for COVID-19 decision-making: a modeling study.

Toh K, Runge M, Richardson R, Hladish T, Gerardin J BMC Infect Dis. 2023; 23(1):287.

PMID: 37142984 PMC: 10158704. DOI: 10.1186/s12879-023-08261-5.

Epidemiologic Parameters for COVID-19: A Systematic Review and Meta-Analysis.

Izadi N, Taherpour N, Mokhayeri Y, Ghorbani S, Rahmani K, Hashemi Nazari S Med J Islam Repub Iran. 2023; 36:155.

PMID: 36654849 PMC: 9832936. DOI: 10.47176/mjiri.36.155.

References
1.
Nishiura H, Kobayashi T, Yang Y, Hayashi K, Miyama T, Kinoshita R . The Rate of Underascertainment of Novel Coronavirus (2019-nCoV) Infection: Estimation Using Japanese Passengers Data on Evacuation Flights. J Clin Med. 2020; 9(2). PMC: 7074297. DOI: 10.3390/jcm9020419. View
2.
. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020; 41(2):145-151. DOI: 10.3760/cma.j.issn.0254-6450.2020.02.003. View
3.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View